Katy Rezvani

Katy Rezvani M.D, PhD is the Sally Cooper Murray Chair in Cancer Research, Professor of Medicine, Chief of Section for Cellular Therapy, Director of Translational Research and Director of the GMP Facility at MD Anderson Cancer Center. She also serves as the Executive Director of the Adoptive Cell Therapy Platform at MD Anderson. Her research laboratory focuses on the role of natural killer (NK) cells in mediating immunity against hematologic and solid tumors.